Nicox S.A. (EPA:ALCOX)
0.4080
-0.0020 (-0.49%)
Apr 2, 2026, 5:35 PM CET
Nicox Market Cap
Nicox has a market cap or net worth of €35.96 million as of April 2, 2026. Its market cap has increased by 99.56% in one year.
Market Cap
35.96M
Enterprise Value
45.10M
Revenue
3.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.41
Market Cap Chart
Since November 3, 1999, Nicox's market cap has decreased from 260.94M to 35.96M, a decrease of -86.22%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 35.96M | 49.10% |
| Dec 31, 2025 | 24.12M | 24.81% |
| Dec 31, 2024 | 19.32M | -12.36% |
| Dec 29, 2023 | 22.05M | -60.51% |
| Dec 30, 2022 | 55.83M | -49.18% |
| Dec 31, 2021 | 109.84M | -31.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adocia | 90.91M |
| OSE Immunotherapeutics | 73.76M |
| Valerio Therapeutics Société anonyme | 59.88M |
| Fermentalg | 46.38M |
| THX Pharma Société Anonyme | 42.08M |
| genOway Société anonyme | 22.96M |
| Advicenne | 21.08M |
| GenSight Biologics | 20.77M |